On ECHEMI

Chengdu Uwin Chemical Co., Ltd

Chengdu,Sichuan,China
Favorite Supplier
 1035 people visit

Company Profile

成都运帷化工有限公司是一家专业从事医药中间体,以及其他化工产品的销售、研发定制和技术服务的科技服务型化工企业。

VIEW MORE VIEW LESS

Product List

Product Name Synonyms CAS No. Grate/Content Operate

(1R,3S,4S)-tert-butyl 3-(6-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]iMidazol-2-yl)-2-azabicyclo[2.2.1]heptane-2-carboxylate

IdentificationName (1R,3S,4S)-3-[6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazol-2-yl]-2-azabicyclo[2.2.1]heptane-2-carboxylic acid 1,1-dimethylethyl ester;tert-butyl (1R,3S,4S)-3-(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazol-2-yl)-2-azabicyclo[2.2.1]heptane-2-carboxylate;(1R,3S,4S)-2-tert-Butyl-3-(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1h-benzo[d]imidazol-2-yl);(1R,3S,4S)-tert-butyl 3-(6-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]iMidazol-2-yl)-2-azabicyclo[2.2.1]heptane-2-carboxylate;2-Azabicyclo[2.2.1]heptane-2-carboxylic acid, 3-[6-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-benziMidazol-2-yl]-, 1,1-diMethylethyl ester, (1R,3S,4S)-;(1R,3S,4S)-3-[6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazol-2-yl]-2-azabicyclo[2.2.1]heptane-2-carboxylic acid 1,1-dimethylethyl ester
1256387-87-7 - / 98% Inquiry

(2R,3R)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol

(2R,3R)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol;2,3-Butanediol, 2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-, (2R,3R)-;Efinaconazole intermediate;(2R,3R)-2-(2,4-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-2,3;(2R,3R)-2-(2,4-difluorophenyl)-1-(1,2,4-triazol-1-yl)butane-2,3-diol;Efinaconazole (2R,3R)-Diol Impurity;(2R,3R)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-dio;Efluconazole impurity 44
133775-25-4 - / 98% Inquiry

(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine 4-methylbenzenesulfonate

(2R,3S)-2-((R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholine 4-methylbenzenesulfonate;(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine 4-methylbenzenesulfonate;C27H26F7NO5S;SCHEMBL3592591;CTK4E2999;DTXSID30469085;BCP07703;0283AB;ANW-54236;AKOS015999500
200000-59-5 - / 98% Inquiry

(3S)-N-Boc-2-azabicyclo[2.2.1]heptane-3-carboxylic acid

2-Azabicyclo[2.2.1]heptane-2,3-dicarboxylic acid,2-(1,1-dimethylethyl) ester,(1R,3S,4S)-;2-(1,1-Dimethylethyl) (1R,3S,4S)-2-azabicyclo[2.2.1]heptane-2,3-dicarboxylate;(1R,3S,4S)-2-(tert-Butoxycarbonyl)-2-azabicyclo[2.2.1]heptane-3-carboxylic acid
291775-59-2 - / 98% Inquiry

(3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine hydrochloride

cis-1-benzyl-N,4-dimethylpiperidin-3-amine dihydro
477600-68-3 - / 98% Inquiry

(5a,11b)-11-[4-(Dimethylamino)phenyl]-5,17-dihydroxy-19-norpregn-9-ene-3,20-dione cyclic bis(1,2-ethanediyl acetal)

(5a,11b)-11-[4-(Dimethylamino)phenyl]-5,17-dihydroxy-19-norpregn-9-ene-3,20-dione cyclic bis(1,2-ethanediyl acetal);(5"R,8"S,11"R,13"S,14"S,17"R)-11"-[4-(dimethylamino)phenyl]-13"-methyl-17"-(2-methyl-1,3-dioxolan-2-
126690-41-3 - / 98% Inquiry

(R)-(+)-1-(1-Naphthyl)ethylamine

1-Naphthalenemethanamine,α-methyl-,(αR)-;1-Naphthalenemethylamine,α-methyl-,(R)-(+)-;1-Naphthalenemethanamine,α-methyl-,(R)-;(αR)-α-Methyl-1-naphthalenemethanamine;(+)-α-(1-Naphthyl)ethylamine;d-1-(1-Naphthyl)ethylamine;(R)-(+)-α-(1-Naphthyl)ethylamine;(+)-1-(1-Naphthyl)ethylamine;(+)-1-(α-Naphthyl)ethylamine;(R)-α-(1-Naphthyl)ethylamine;(R)-1-(1-Naphthyl)ethylamine;(R)-1-(α-Naphthyl)ethylamine;(R)-(+)-1-(1-Naphthyl)ethylamine;(R)-(+)-1-(α-Naphthyl)ethylamine;(R)-1-(1-Naphthyl)ethanamine;(R)-1-Naphthylethylamine;(R)-α-Methyl-1-naphthalenemethanamine;(R)-(+)-1-(1-Naphthyl)ethylamine;[(R)-1-(Naphthalen-1-yl)ethyl]amine;(1R)-1-(1-Naphthyl)ethanamine;(R)-1-(Naphthalen-1-yl)ethanamine;(+)-[(R)-1-(Naphthalen-1-yl)ethyl]amine;(R)-1-(1-Naphthalenyl)ethylamine;(R)-1-(Naphthalen-1-yl)ethan-1-amine;(1R)-1-(Naphthalen-1-yl)ethan-1-amine;(1R)-1-Naphthalen-1-ylethanamine
3886-70-2 - / 98% Inquiry

(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethanol

171482-05-6 - / 98% Inquiry

(R)-3-Piperidinamine dihydrochloride

3-Piperidinamine,hydrochloride (1:2),(3R)-;3-Piperidinamine,dihydrochloride,(3R)-;(R)-3-Aminopiperidine dihydrochloride;(R)-(-)-3-Aminopiperidine dihydrochloride;(R)-Piperidin-3-amine dihydrochloride;(R)-Piperidin-3-amine dihydrochloride
334618-23-4 - / 98% Inquiry

1,2,3-Triacetyl-5-deoxy-D-ribose

β-D-Ribofuranose,5-deoxy-,1,2,3-triacetate;β-D-Ribofuranose,5-deoxy-,triacetate;1,2,3-Tri-O-acetyl-5-deoxy-β-D-ribofuranose
62211-93-2 - / 98% Inquiry

1-(2-broMo-5-fluorobenzyl)-6-chloro-3-MethylpriMidine-2,4(1H, 3H)-dione

Benzonitrile,2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-4-fluoro-;2-[[6-[(3R)-3-Amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-4-fluorobenzonitrile;Trelagliptin;(R)-2-[[6-(3-Aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl]methyl]-4-fluorobenzonitrile;(R)-2-[[6-(3-AMinopiperidin-1-yl)-3-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl]Methyl]-4-fluorobenzonitrile;2-[[6-[(3R)-3-Aminopiperidin-1-yl]-3-methyl-2,4-dioxopyrimidin-1-yl]methyl]-4-fluorobenzonitrile
865759-25-7 - / 98% Inquiry

1-(2-chloro-4-hydroxyphenyl)-3-cyclopropylurea

1-(2-chloro-4-hydroxyphenyl)-3-cyclopropylurea;N-(2-chloro-4-hydroxyphenyl)-N'-cyclopropyl-Urea;Urea, N-(2-chloro-4-hydroxyphenyl)-N'-cyclopropyl-;Lenvatinib Impurity a;(Z)-N-(2-chloro-4-hydroxyphenyl)-N-cyclopropylcarbamimidic acid;Lenvatinib Impurity 6;lenvaint-I
796848-79-8 - / 98% Inquiry

1-(7-broMo-9,9-difluoro-9H-fluoren-2-yl)-2-chloro-Ethanone

Ethanone,1-(7-bromo-9,9-difluoro-9H-fluoren-2-yl)-2-chloro-;1-(7-Bromo-9,9-difluoro-9H-fluoren-2-yl)-2-chloroethanone;1-(7-Bromo-9,9-difluorofluoren-2-yl)-2-chloroethanone
1378387-81-5 - / 98% Inquiry

1-BOC-4-(6-AMINOPYRIDIN-3-YL)PIPERAZINE

1-Piperazinecarboxylic acid,4-(6-amino-3-pyridinyl)-,1,1-dimethylethyl ester;4-(6-Aminopyridin-3-yl)piperazine-1-carboxylic acid tert-butyl ester;4-(6-Aminopyridin-3-yl)piperazine-1-carboxylic acid tert-butyl ester;tert-Butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate;tert-Butyl 4-(6-amino-3-pyridyl)piperazine-1-carboxylate;1-Boc-4-(6-aminopyridin-3-yl)piperazine
571188-59-5 - / 98% Inquiry

1-Boc-4-methylenepiperidine

TERT-BUTYL 4-METHYLENEPIPERIDINE-1-CARBOXYLATE;N-BOC-4-METHYLENEPIPERIDINE;1-N-BOC-4-METHYLENE-PIPERIDINE;4-METHYLENE-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER;4-METHYLENEPIPERIDINE, N-BOC PROTECTED;1-Boc-4-Methylene-piperidine;4-Methylenepiperidine, N-BOC protected 97%;Boc-4-methylenepiperidine
159635-49-1 - / 98% Inquiry

1-PIPERIDINEPROPANENITRILE, 4-METHYL-3-(METHYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YLAMINO)-BETA-OXO-, (3R,4R)-, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE (1:1)

1-Piperidinepropanenitrile,4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-,(3R,4R)-,2-hydroxy-1,2,3-propanetricarboxylate (1:1);3-Piperidinamine,1-(cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo[2,3-d]pyrimidin-4-yl-,(3R,4R)-,2-hydroxy-1,2,3-propanetricarboxylate (1:1);Tasocitinib citrate;CP 690500-10;Tofacitinib citrate;CP 690550-10;Xeljanz;Xeljanz XR
540737-29-9 - / 98% Inquiry

1. 1-(((2R, 3S)-2-(2,4-difluorophenyl)-3-Methyloxiran-2-yl) Methyl)-1H-1,2,4-triazole

127000-90-2;1-(((2R,3S)-2-(2,4-difluorophenyl)-3-methyloxiran-2-yl)methyl)-1H-1,2,4-triazole;UNII-D1JO8189W7;(2R,3S)-2-(2,4-difluorophenyl)-3-methyl-2-[(1H-1,2,4-triazole-1-yl)methyl]oxirane;D1JO8189W7;1-[[(2R,3S)-2-(2,4-difluorophenyl)-3-methyloxiran-2-yl]methyl]-1,2,4-triazole;1-{[(2R,3S)-2-(2,4-difluorophenyl)-3-methyloxiran-2-yl]methyl}-1H-1,2,4-triazole;1H-1,2,4-Triazole, 1-[[(2R,3S)-2-(2,4-difluorophenyl)-3-methyloxiranyl]methyl]-;124627-86-7;132563-77-0
127000-90-2 - / 98% Inquiry

11β-[4-(N,N-diMethylaMino)-phenyl]-17α-hydroxy-19-norpregna-4,9-diene-3,20-dione;Ulipristal acetate InterMediate

17alpha-acetoxy-11beta-(4-N,N-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione;CDB 2914;CDB-2914;HRP 2000;HRP-2000;RTI-3021-012;RTI-3021-022;ulipristal;VA-2914;VA2914
159811-51-5 - / 98% Inquiry

17-Hydroxy-19-norpregna-4,9-diene-3,20-dione

17-Hydroxy-19-norpregna-4,9-diene-3,20-dione
14340-01-3 - / 98% Inquiry

17α-Acetoxy-11β-(4-dimethylaminophenyl)-19-norpregna-4,9-dien-3,20-dione

19-Norpregna-4,9-diene-3,20-dione,17-(acetyloxy)-11-[4-(dimethylamino)phenyl]-,(11β)-;(11β)-17-(Acetyloxy)-11-[4-(dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione;CDB 2914;RTI 3021-012;CBD(VA) 2914;VA 2914;17α-Acetoxy-11β-(4-dimethylaminophenyl)-19-norpregna-4,9-dien-3,20-dione;RU 44675;HRP 2000;Ulipristal acetate;17α-Acetoxy-11β-[4-N,N-dimethylaminophenyl]-19-norpregna-4,9-diene-3,20-dione;EllaOne;Esmya;17-Acetoxy-11β-[(4-(N,N-dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione;17-Acetyloxy-11β-[(4-(N,N-dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione;17-Acetoxy-11β-[(4-(dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione;136960-00-4;199015-61-7;1379515-47-5
126784-99-4 - / 98% Inquiry

CONTACT INFORMATION

Send an inquiry

Product Name:
Quantity:
Shipment Term:

United States

  • China
  • Albania
  • Algeria
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Brazil
  • Brunei
  • Bulgaria
  • Burkina-faso
  • Burundi
  • Cameroon
  • Canada
  • Cape Verde
  • Cayman Islands
  • Central African
  • Chad
  • Chile
  • Colombia
  • Comoros
  • Cook Is.
  • Costa Rica
  • Croatia
  • Curacao
  • Cyprus
  • Czech
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Honduras
  • Hongkong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Ivory Coast
  • Jamaica
  • Japan
  • Jordan
  • Kampuchea (Cambodia )
  • Kazakstan
  • Kenya
  • Kiribati
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macao, China
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Island
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Norfolk Island
  • North Macedonia
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Cuinea
  • Paraguay
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Republic of the Congo
  • Reunion Island
  • Romania
  • Russia
  • Rwanda
  • Saint Kitts and Nevis
  • Saint Martin
  • Saint Vincent and the Grenadines
  • Samoa
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Slovakia
  • Slovenia
  • Solomon Is
  • Somali
  • South Africa
  • South Korea
  • South Sudan
  • Spain
  • Sri Lanka
  • St.Lucia
  • Suriname
  • Swaziland
  • Sweden
  • Switzerland
  • Taiwan, China
  • Tajikstan
  • Tanzania
  • Thailand
  • The British Virgin Islands
  • The Dominican Republic
  • The Islamic Republic of Mauritania
  • The Islands of st pierre and miquelon
  • The Turks and Caicos Islands
  • Timor-Leste
  • Togo
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Tuvalu
  • Uganda
  • United Arab Emirates
  • United Kingdom
  • United States
  • Uruguay
  • Uzbekistan
  • Vanuatu
  • Vatican
  • Vietnam
  • Wallis et Futuna
  • Western Sahara
  • Yemen
  • Zaire
  • Zambia
  • Zimbabwe
  • Afghanistan
  • Belarus
  • Cuba
  • Iran
  • Iraq
  • Libya
  • North Korea
  • Sudan
  • Syria
  • Ukraine
  • Venezuela
Message:
0/2000
Accept quotations from other qualified suppliers on ECHEMI.com

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.